EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Painful Diabetic Neuropathy
Interventions
DRUG

ISA specific

ISA specific interventions will be listed in their protocols.

Trial Locations (23)

10032

RECRUITING

Columbia University Medical Center/Neurological Institute, New York

10451

RECRUITING

Mount Sinai School of Medicine, New York

14627

RECRUITING

University of Rochester, Rochester

15206

RECRUITING

University of Pittsburgh, Pittsburgh

21201

RECRUITING

University of Maryland - Baltimore, Baltimore

21205

RECRUITING

Johns Hopkins University School of Medicine, Baltimore

23298

RECRUITING

VCU Department of Neurology, Richmond

23510

RECRUITING

Eastern Virginia Medical School, Norfolk

29118

RECRUITING

Low Country Pain Center, Orangeburg

32607

RECRUITING

SIMEDHealth LLC, Gainesville

32611

RECRUITING

University of Florida, Gainesville

RECRUITING

University of Washington, Seattle

34711

TERMINATED

South Lake Pain Institute, Clermont

45431

RECRUITING

Clinical Inquest Center, Beavercreek

53706

RECRUITING

University of Wisconsin, Madison

60422

RECRUITING

Healthcare Research Network (Flossmoor), Flossmoor

60611

RECRUITING

Northwestern Department of Neurology, Chicago

63042

RECRUITING

Healthcare Research Network (Hazelwood), Hazelwood

66160

RECRUITING

University of Kansas Medical Center, Kansas City

77030

RECRUITING

Nerve and Muscle Center of Texas, Houston

84132

RECRUITING

University of Utah School of Medicine, Salt Lake City

92037

RECRUITING

University of California, San Diego, San Diego

02114

TERMINATED

MGH Department of Anesthesia, Critical Care, and Pain, Boston

All Listed Sponsors
collaborator

New York University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

James P. Rathmell, MD

OTHER